SCHEMBL26167142

SCHEMBL26167142

CC(C)(C)OC(=O)N(Cc1ccccc1)C(C)(C=O)CO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
NCOR2 Q9Y618 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HTT P42858 1/20 0.46
AKT1 P31749 3/20 0.43
CTSL P07711 2/20 0.42
CTSB P07858 2/20 0.42
CTSS P25774 2/20 0.42
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD11B1 P28845 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18706832 0.78 HDAC3 (0.45) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL18707214 0.78 HDAC3 (0.45) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL18707238 0.78 HDAC3 (0.45) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL26326088 0.77 AKT1 (0.50) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL2794680 0.77 HDAC3 (0.51) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL2722481 0.76 HDAC3 (0.53) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL28532859 0.76 HDAC3 (0.53) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL8352132 0.76 AKT1 (0.46) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL22035107 0.75 HDAC1 (0.52) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL3819098 0.75 AKT1 (0.52) HDAC3HDAC1HDAC2NCOR2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023099592-A1 ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-06-08 WO disclosed